Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schrader

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Immuno-Oncology Technology|July 24, 2024
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanomaI A J van Duin, M Schuiveling, L S Ter Maat, et al.
Blood|March 9, 2018
High prevalence of <i>MYD88</i> and <i>CD79B</i> mutations in intravascular large B-cell lymphomaAnne M R Schrader, Patty M Jansen, Rein Willemze, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with responseMark Schuiveling, Isabella A J van Duin, Laurens S Ter Maat, et al.
JAMA Oncology|October 16, 2025
Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated MelanomaMark Schuiveling, Isabella A J van Duin, Laurens S Ter Maat, et al.
The British Journal of Dermatology|August 12, 2025
EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disordersRein Willemze, Chalid Assaf, Martine Bagot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2026
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluationN G Koster, J M P A van den Reek, E M G J de Jong, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Immuno-Oncology Technology|July 24, 2024
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanomaI A J van Duin, M Schuiveling, L S Ter Maat, et al.
Blood|March 9, 2018
High prevalence of <i>MYD88</i> and <i>CD79B</i> mutations in intravascular large B-cell lymphomaAnne M R Schrader, Patty M Jansen, Rein Willemze, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with responseMark Schuiveling, Isabella A J van Duin, Laurens S Ter Maat, et al.
JAMA Oncology|October 16, 2025
Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated MelanomaMark Schuiveling, Isabella A J van Duin, Laurens S Ter Maat, et al.
The British Journal of Dermatology|August 12, 2025
EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disordersRein Willemze, Chalid Assaf, Martine Bagot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2026
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluationN G Koster, J M P A van den Reek, E M G J de Jong, et al.
Pageof 8